Inactive Instrument
CEREP Share Price Euronext Paris
Stocks
FR0004042232
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-29 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 02/10/25 | Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 82.22M 94.65M 76.35M 70.41M 133M 9.04B 135M 904M 354M 4.49B 355M 348M 15.09B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 61.18M 70.44M 56.82M 52.4M 98.7M 6.72B 100M 673M 263M 3.34B 265M 259M 11.23B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 10/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodolphe Simonot
BRD | Director/Board Member | - | - |
Paul Ratcliffe
CHM | Chairman | - | 10/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 22/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.80% | +5.16% | -0.70% | +12.87% | 48.95B | |
| -3.69% | +14.51% | +23.94% | +6.10% | 40.75B | |
| +4.54% | +0.22% | +411.04% | +620.61% | 38.46B | |
| -1.86% | -1.95% | +6.82% | +49.57% | 36.38B | |
| +5.56% | +11.70% | +11.64% | +51.50% | 28.45B | |
| -0.92% | -1.58% | - | - | 16.62B | |
| -0.97% | -4.67% | +31.92% | +128.11% | 16.33B | |
| -5.81% | -0.99% | -7.09% | -32.92% | 13.65B | |
| -0.06% | +3.75% | +3.81% | +9.62% | 13.56B | |
| Average | -0.36% | +6.06% | +60.17% | +105.68% | 28.13B | |
| Weighted average by Cap. | +0.01% | +7.20% | +75.29% | +125.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.61M 37.6M 34.67M 65.31M 4.45B 66.5M 445M 174M 2.21B 175M 171M 7.43B | 41.1M 47.32M 38.17M 35.2M 66.3M 4.52B 67.5M 452M 177M 2.24B 178M 174M 7.54B |
| Net income | 7.15M 8.24M 6.64M 6.13M 11.54M 786M 11.75M 78.66M 30.8M 391M 30.93M 30.25M 1.31B | 4.78M 5.51M 4.44M 4.1M 7.72M 526M 7.85M 52.58M 20.59M 261M 20.68M 20.22M 878M |
| Net Debt | -17.25M -19.86M -16.02M -14.78M -27.83M -1.9B -28.34M -190M -74.27M -942M -74.59M -72.96M -3.17B | -21.03M -24.22M -19.53M -18.01M -33.93M -2.31B -34.55M -231M -90.54M -1.15B -90.94M -88.95M -3.86B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
